TESTOST AQ MDV 50MG/ML INJ — Class II drug recall D-0783-2017
Terminated recall by Key Pharmacy and Compounding Center, reported 2017-05-24, distributed nationwide. Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of as
| Recall number | D-0783-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Key Pharmacy and Compounding Center, Federal Way, WA, United States |
| Recall initiated | 2017-04-18 |
| Classified | 2017-05-17 |
| Reported by FDA | 2017-05-24 |
| Terminated | 2017-08-29 |
| Distributed | Nationwide (US) |
| Countries outside the US | AU, CA |
| Reason classes | sterility |
| Lot numbers | T02 |
| Expiration dates | 2017-05-14, 2017-05-24 |
Product
TESTOST AQ MDV 50MG/ML INJ, Injection, 50mg/mL, Rx only, packaged in 5mL and 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy
Reason for recall
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0783-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.